| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.744 | 34.186 | 39.206 | 46.408 | 46.882 | 43.120 | 50.591 | 72.430 | 76.972 |
| Total Income - EUR | - | 5.744 | 34.187 | 39.209 | 46.414 | 48.950 | 43.122 | 50.592 | 72.431 | 76.974 |
| Total Expenses - EUR | - | 3.323 | 19.417 | 21.451 | 22.478 | 26.128 | 22.136 | 30.309 | 38.353 | 53.420 |
| Gross Profit/Loss - EUR | - | 2.421 | 14.770 | 17.759 | 23.936 | 22.822 | 20.986 | 20.283 | 34.078 | 23.554 |
| Net Profit/Loss - EUR | - | 2.364 | 14.427 | 17.366 | 23.475 | 22.356 | 20.554 | 19.777 | 33.351 | 21.246 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Carleta Merlan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 461 | 194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.175 | 17.957 | 29.542 | 23.689 | 26.083 | 22.127 | 22.457 | 37.886 | 25.252 |
| Inventories | - | 94 | 92 | 90 | 389 | 462 | 452 | 454 | 452 | 450 |
| Receivables | - | 154 | 123 | 588 | 21.729 | 20.866 | 17.428 | 18.545 | 25.424 | 13.040 |
| Cash | - | 2.928 | 17.742 | 28.864 | 1.570 | 4.755 | 4.247 | 3.459 | 12.010 | 11.762 |
| Shareholders Funds | - | 2.408 | 14.480 | 17.418 | 22.037 | 22.406 | 20.603 | 19.826 | 33.400 | 21.294 |
| Social Capital | - | 45 | 44 | 43 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.228 | 3.671 | 12.124 | 1.651 | 3.677 | 1.524 | 2.631 | 4.486 | 3.958 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Carleta Merlan Med Srl